Docetaxel related neutropenic sepsis rate in breast cancer patients during adjuvant and neoadjuvant chemotherapy; a retrospective study

被引：0
|
作者：
Elmahdawi, N. [1 ]
Davies, M. [1 ]
Upadhyay, S. [1 ]
O'Neill, P. [1 ]
机构：
[1] Queens Ctr Oncol, Kingston Upon Hull, N Humberside, England
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70399-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [21] The Rate of Lymphedema and Predictive Factors in the Setting of Neoadjuvant Chemotherapy and Adjuvant Radiation Therapy in Breast Cancer Patients
    Altoos, B., Jr.
    Refaat, T.
    Ho, Y.
    Wesolowski, M.
    Small, W., Jr.
    Thomas, T. O., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E49 - E49
  • [22] Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study
    Akinci, M. Bulent
    Algin, E.
    Inal, A.
    Odabas, H.
    Berk, V.
    Coskun, U.
    Uyeturk, U.
    Isikdogan, A.
    Aksoy, S.
    Civelek, B.
    Sevinc, A.
    Buyukberber, S.
    JOURNAL OF BUON, 2013, 18 (02): : 314 - 320
  • [23] Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study
    Chen, Jida
    Jin, Lidan
    Chen, Lini
    Bian, Zilong
    Li, Zhaoqing
    Cao, Shuyin
    Zhou, Jichun
    Xu, Ling
    Zhao, Wenhe
    Wang, Qinchuan
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
  • [24] Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
    Gradishar, WJ
    Wedam, SB
    Jahanzeb, M
    Erban, J
    Limentani, SA
    Tsai, KT
    Olsen, SR
    Swain, SM
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1297 - 1304
  • [25] Features of neoadjuvant and adjuvant chemotherapy in breast cancer - A population-based study on 39404 patients
    von Minckwitz, G.
    Kern, P.
    Schneeweiss, A.
    Gluz, O.
    Harbeck, N.
    Neumann, M.
    Badiian, M.
    Fries, H.
    Rezai, M.
    CANCER RESEARCH, 2013, 73
  • [26] Sleep Aid Prescribing Practices during Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer
    Costantini, Carrie
    Ale-Ali, Amine
    Helsten, Teresa
    JOURNAL OF PALLIATIVE MEDICINE, 2011, 14 (05) : 563 - 566
  • [27] Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort study
    Kwok, Carol C. H.
    Wong, W. H.
    Chan, Landon L.
    Wong, Sabrina P. Y.
    Wang, F.
    Wong, Martin C. S.
    Tse, Shelly L. A.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (06) : 438 - 446
  • [28] The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
    He, Hongbo
    Zhang, Peng
    Li, Feng
    Liu, Donglei
    Wu, Kai
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (06) : 2736 - 2748
  • [29] Docetaxel and anthracycline-based neoadjuvant chemotherapy in breast cancer
    Tiezzi, D. G.
    Andrade, J. M.
    Macchetti, A. H.
    Clagnan, W. S.
    Marana, H. R.
    Zola, F. E.
    Peria, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
    Smith, IC
    Heys, SD
    Hutckeon, AW
    Miller, ID
    Payne, S
    Gilbert, FJ
    Ah-See, AK
    Eremin, O
    Walker, LG
    Sarkar, TK
    Eggleton, SP
    Ogston, KN
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1456 - 1466
12345